The ketogenic diet is a highly feasible, safe, and potentially transformative intervention for serious mental illness.
A new study has mapped widespread differences in the white matter communication networks of individuals with bipolar disorder.
New research identifies a specific pathway where insulin resistance leads to gray matter loss and cognitive impairment in BD patients, but not those with Major Depression. This discovery opens the door for personalized treatments, such as GLP-1 agonists, to target the metabolic roots of cognitive decline.
A digital helping hand or a dangerous mirror? New research reveals how AI chatbots can consolidate delusions and worsen symptoms for those with severe mental illness.
One hit could have a two-year countdown. New research confirms that teen cannabis use doubles the risk of severe psychiatric disorders in young adulthood.
For the first time, lab-grown mini brains have revealed how neurons misfire in schizophrenia and bipolar disorder. Using machine learning to analyze electrical activity, researchers identified distinct firing patterns that served as biomarkers, distinguishing patient-derived organoids from healthy ones with over 90% accuracy.
A large multicenter study has revealed that sex influences the course and characteristics of schizophrenia and bipolar disorder. Women with schizophrenia tended to begin treatment later, while men with schizophrenia had the highest rates of substance use.
A new study uncovers a pancreas–hippocampus feedback loop that may help explain mood swings in bipolar disorder. Using patient-derived pancreatic islets, researchers found reduced insulin secretion linked to elevated RORβ, a bipolar risk gene.
A groundbreaking study has revealed that genes linked to mental and neurodegenerative disorders, such as autism, depression, and Parkinson’s, begin influencing brain development during the earliest fetal stages. These genes are already active in neural stem cells—the progenitors that form the brain—long before symptoms arise.
Researchers have discovered hepatitis C virus (HCV) in the brain lining of individuals with schizophrenia and bipolar disorder, suggesting a possible link between infection and psychiatric symptoms. The study found HCV specifically in the choroid plexus, a structure producing cerebrospinal fluid, but not inside brain tissue itself.
A new review has examined how bipolar disorder medications interact with the gut microbiome, revealing important links between treatment response and gut microbial composition. Researchers analyzed 12 studies comparing the microbiomes of treated, untreated, and healthy individuals.
A new long-term study confirms that children of parents with schizophrenia or bipolar disorder face a higher risk of developing mental health issues compared to peers without parental psychiatric diagnoses. Over four years, researchers tracked 238 children and found distinct patterns of symptoms depending on whether a parent had schizophrenia or bipolar disorder.
